introduction to cns pharmacology kfu 1
TRANSCRIPT
-
7/29/2019 Introduction to CNS Pharmacology KFU 1
1/24
Introduction to CNS
pharmacologyBY
Emeka P MCCP-KFU
-
7/29/2019 Introduction to CNS Pharmacology KFU 1
2/24
Microanatomy
Neurons
Non-neuronal:-
-Microglia
-Microglial related macrophages-Meninges
-
7/29/2019 Introduction to CNS Pharmacology KFU 1
3/24
Blood brain barrier
Blood brain barrier (BBB)
Cortical microvasculature
-
7/29/2019 Introduction to CNS Pharmacology KFU 1
4/24
The BBB has several functions
Protects the brain from foreign substances "in the
blood that may injure the brain may injure the brain
Protects the brain from hormones and
neurotransmitters in the rest of the body
Maintains a constant environment for the brain
-
7/29/2019 Introduction to CNS Pharmacology KFU 1
5/24
General properties
Large molecules do not pass through the BBB easily.
Low lipid (fat) soluble molecules do not penetrate into
the brain. However lipid soluble molecules e.g.
barbiturate drugs rapidly cross through the brain.
Molecules that have a high electrical charge are
slowed
-
7/29/2019 Introduction to CNS Pharmacology KFU 1
6/24
Transport of substances into the
brain are dependent on: Conc between compartments
Size of molecule (MW)
Flexibility and conformation of molecules
Amino acid composition
Lipophilicity
Cellular enzymatic stability
Cellular sequestration Affinity for efflux mechanisms
Hydrogen bonding potentials (charge)
Affinity for carrier mechanisms
Effects of existing pathological conditions
-
7/29/2019 Introduction to CNS Pharmacology KFU 1
7/24
Factors determining the ability of a
drug to cross the blood-brain barrier
1. Lipid solubility
2. Ionization
3. Plasma protein binding Passive Molecular mass
Transporter Active
-
7/29/2019 Introduction to CNS Pharmacology KFU 1
8/24
Diffusion of substances in the
brainParacellular(between cells) (not occur to great
extent at the BBB due to tight junctions)
Transcellular(across cells) The higher the
lipohilicity of a substance the greater the
diffusion in the brain
-
7/29/2019 Introduction to CNS Pharmacology KFU 1
9/24
Communication among neurons
Chemical synapses:-
- Electrotonic junctions.
-Electrical field interactions.
- Extracellular milieu.
-
7/29/2019 Introduction to CNS Pharmacology KFU 1
10/24
Circumventricular Organs
Area postrema: vomiting centre when a toxic substance enters thebloodstream.
Vascular organ of the lamina terminalis: A chemosensory area thatdetects peptides and other molecules.
Pineal body: Secretes melatonin and neurosctive peptodes, associatedwith circadian rhythms
-
7/29/2019 Introduction to CNS Pharmacology KFU 1
11/24
Strategies for drug delivery
through the blood-brain barrier Invasive
-intracarotid infusion of hypertonic media.
2. Pharmacologic
-liposomes
-lipid-soluble pro-drugs
3. Physiologic
-chimeric nutrients
-chimeric peptides
-
7/29/2019 Introduction to CNS Pharmacology KFU 1
12/24
Communication in CNS
Conduction of nerve impulses within
a single neuron.
Communication among neurons.
-
7/29/2019 Introduction to CNS Pharmacology KFU 1
13/24
Ion Channels in Neuronal
Membrane 1. Voltage sensitive.
2. Chemically activated (receptor
operated).
-
7/29/2019 Introduction to CNS Pharmacology KFU 1
14/24
CNS synapse1.Axonal transport.
2.electrically excitable membrane.
3.Transmitter synthesis, storage
and metabolism.
4. Transmitter uptake
5. Transmitter release6. Postsynaptic receptors,
cytoplasmic organelles,
messengers, etc.
7. Presynaptic heteroreceptors
8. Presynaptic autoreceptors
-
7/29/2019 Introduction to CNS Pharmacology KFU 1
15/24
Chemical synapses and other forms of
neurohumoral communication
Neurotransmitters.
Neuromodulators.
Neurohormones.
-
7/29/2019 Introduction to CNS Pharmacology KFU 1
16/24
Identification ofCNS
Neurotransmitters - Criteria
Localization.
Release.
Synaptic mimicry:-
-Identity of action
-Pharmacologic identity (antagonists)
-
7/29/2019 Introduction to CNS Pharmacology KFU 1
17/24
Neurotransmitters in the CNS
Catecholamines:-
Dopamine
-
7/29/2019 Introduction to CNS Pharmacology KFU 1
18/24
Neurotransmitters in the CNS
Catecholamine:-
Noradrenaline
-
7/29/2019 Introduction to CNS Pharmacology KFU 1
19/24
Neurotransmitters in the CNSCatecholamine:-
5-hydroxytryptamine,
5-HT, serotonin
-
7/29/2019 Introduction to CNS Pharmacology KFU 1
20/24
Neurotransmitters in the CNS
Acetylcholine:-
Renshaw cells
interneurons in the striatum
medial septum n. hippocampus
n. basalis Meynert cortex
-
7/29/2019 Introduction to CNS Pharmacology KFU 1
21/24
Neurotransmitters in the CNS
GLUTAMIC ACID
Excitatory for most neurons.
N-methyl-D-aspartate (NMDA) receptor Learning and memory.
GABA AND GLYCINE
GABA is the primary NTA mediatingInhibitory effects (IPSPs)
-
7/29/2019 Introduction to CNS Pharmacology KFU 1
22/24
Neurotransmitters in the CNS
Peptides
Opioid peptides
Substance P
Somatostatin, etc.
Nitric oxide
-
7/29/2019 Introduction to CNS Pharmacology KFU 1
23/24
General Characteristics of CNS
Drugs
Nonspecific: effect on many different targets
cells & results in diverse molecular mechanism(anesthetic gases).
2. Specific: binds to a target cell receptor,
intracellular mechanism and imparts a specifictherapeutic action. (psychotropic drugs).
-
7/29/2019 Introduction to CNS Pharmacology KFU 1
24/24
Classification of drugs
acting on CNS They are Classified into 2 major groups:-
According to
1. Mechanism of action.
2. Therapeutic use.